Low-dose IL-2 selectively activates subsets of CD4+ Tregs and NK cells-Reference-Cited by-同舟云学术

Low-dose IL-2 selectively activates subsets of CD4+ Tregs and NK cells

Published:2016-11-03 Issue:18 Volume:1 Page:
ISSN:2379-3708
Container-title:JCI Insight
language:en
Short-container-title:

Author:

Hirakawa Masahiro,Matos Tiago,Liu Hongye,Koreth John,Kim Haesook T.,Paul Nicole E.,Murase Kazuyuki,Whangbo Jennifer,Alho Ana C.,Nikiforow Sarah,Cutler Corey,Ho Vincent T.,Armand Philippe,Alyea Edwin P.,Antin Joseph H.,Blazar Bruce R.,Lacerda Joao F.,Soiffer Robert J.,Ritz Jerome

Publisher

American Society for Clinical Investigation

Subject

General Medicine

Reference63 articles.

1. Life Expectancy in Patients Surviving More Than 5 Years After Hematopoietic Cell Transplantation

2. Long-Term Survival and Late Deaths After Allogeneic Hematopoietic Cell Transplantation

3. Current issues in chronic graft-versus-host disease

4. Advances in graft-versus-host disease biology and therapy

5. Recovery of B-cell homeostasis after rituximab in chronic graft-versus-host disease

Cited by 118 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Assessment of SLEDAI score changes in systemic lupus erythematosus patients under low-dose interleukin-2 therapy: A meta-analysis;Clinical Epidemiology and Global Health;2024-09

2. Bridging therapy-induced phenotypes and genetic immune dysregulation to study interleukin-2-induced immunotoxicology;Clinical Immunology;2024-09

3. The impact of regulatory T cells on the graft-versus-leukemia effect;Frontiers in Immunology;2024-04-22

4. A CD25-biased interleukin-2 for autoimmune therapy engineered via a semi-synthetic organism;Communications Medicine;2024-03-26

5. Insufficient phosphorylation of STAT5 in Tregs inhibits the expression of BLIMP-1 but not IRF4, reduction the proportion of Tregs in pediatric aplastic anemia;Heliyon;2024-03